A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2

被引:106
作者
Dusonchet, Julien
Kochubey, Olexiy [2 ]
Stafa, Klodjan [3 ]
Young, Samuel M., Jr. [4 ]
Zufferey, Romain
Moore, Darren J. [3 ]
Schneider, Bernard L.
Aebischer, Patrick [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, EPFL SV BMI LEN, CH-1015 Lausanne, Switzerland
[2] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland
[3] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland
[4] Max Planck Florida Inst Integrat Biol & Neurosci, Jupiter, FL 33458 USA
基金
瑞士国家科学基金会;
关键词
ADENOVIRAL VECTORS; MICE; EXPRESSION; BRAIN;
D O I
10.1523/JNEUROSCI.5092-10.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The G2019S mutation in the leucine-rich repeat kinase 2 (LRRK2) gene is the most common genetic cause of Parkinson's disease (PD), accounting for a significant proportion of both autosomal dominant familial and sporadic PD cases. Our aim in the present study is to generate a mammalian model of mutant G2019S LRRK2 pathogenesis, which reproduces the robust nigral neurodegeneration characteristic of PD. We developed adenoviral vectors to drive neuron-specific expression of full-length wild-type or mutant G2019S human LRRK2 in the nigrostriatal system of adult rats. Wild-type LRRK2 did not induce any significant neuronal loss. In contrast, under the same conditions and levels of expression, G2019S mutant LRRK2 causes a progressive degeneration of nigral dopaminergic neurons. Our data provide a novel rat model of PD, based on a prevalent genetic cause, that reproduces a cardinal feature of the disease within a rapid time frame suitable for testing of neuroprotective strategies.
引用
收藏
页码:907 / 912
页数:6
相关论文
共 21 条
  • [1] Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease
    Berg, D
    Schweitzer, KJ
    Leitner, P
    Zimprich, A
    Lichtner, P
    Belcredi, P
    Brüssel, T
    Schulte, C
    Maass, S
    Nägele, T
    Wszolek, ZK
    Gasser, T
    [J]. BRAIN, 2005, 128 : 3000 - 3011
  • [2] Localization of LRRK2 to membranous and vesicular structures in mammalian brain
    Biskup, Saskia
    Moore, Darren J.
    Celsi, Fulvio
    Higashi, Shinji
    West, Andrew B.
    Andrabi, Shaida A.
    Kurkinen, Kaisa
    Yu, Seong-Woon
    Savitt, Joseph M.
    Waldvogel, Henry J.
    Faull, Richard L. M.
    Emson, Piers C.
    Torp, Reldun
    Ottersen, Ole P.
    Dawson, Ted M.
    Dawson, Valina L.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 (05) : 557 - 569
  • [3] Di Fonzo A, 2005, LANCET, V365, P412
  • [4] Biochemical and pathological characterization of Lrrk2
    Giasson, BI
    Covy, JP
    Bonini, NM
    Hurtig, HI
    Farrer, MJ
    Trojanowski, JQ
    Van Deerlin, VM
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (02) : 315 - 322
  • [5] Common LRRK2 mutation in idiopathic Parkinson's disease
    Gilks, WP
    Abou-Sleiman, PM
    Gandhi, S
    Jain, S
    Singleton, A
    Lees, AJ
    Shaw, K
    Bhatia, KP
    Bonifati, V
    Quinn, NP
    Lynch, J
    Healy, DG
    Holton, JL
    Revesz, T
    Wood, NW
    [J]. LANCET, 2005, 365 (9457) : 415 - 416
  • [6] Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
    Healy, Daniel G.
    Falchi, Mario
    O'Sullivan, Sean S.
    Bonifati, Vincenzo
    Durr, Alexandra
    Bressman, Susan
    Brice, Alexis
    Aasly, Jan
    Zabetian, Cyrus P.
    Goldwurm, Stefano
    Ferreira, Joaquim J.
    Tolosa, Eduardo
    Kay, Denise M.
    Klein, Christine
    Williams, David R.
    Marras, Connie
    Lang, Anthony E.
    KWszolek, Zbigniew
    Berciano, Jose
    Schapira, Anthony H. V.
    Lynch, Timothy
    Bhatia, Kailash P.
    Gasser, Thomas
    Lees, Andrew J.
    Wood, Nicholas W.
    [J]. LANCET NEUROLOGY, 2008, 7 (07) : 583 - 590
  • [7] Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area
    Kügler, S
    Kilic, E
    Bähr, M
    [J]. GENE THERAPY, 2003, 10 (04) : 337 - 347
  • [8] Neuron-specific expression of therapeutic proteins:: Evaluation of different cellular promoters in recombinant adenoviral vectors
    Kügler, S
    Meyn, L
    Holzmüller, H
    Gerhardt, E
    Isenmann, S
    Schulz, JB
    Bähr, M
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 17 (01) : 78 - 96
  • [9] Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
    Lee, Byoung Dae
    Shin, Joo-Ho
    VanKampen, Jackalina
    Petrucelli, Leonard
    West, Andrew B.
    Ko, Han Seok
    Lee, Yun-Il
    Maguire-Zeiss, Kathleen A.
    Bowers, William J.
    Federoff, Howard J.
    Dawson, Valina L.
    Dawson, Ted M.
    [J]. NATURE MEDICINE, 2010, 16 (09) : 998 - 1000
  • [10] LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
    Lesage, S
    Dürr, A
    Tazir, M
    Lohmann, E
    Leutenegger, AL
    Janin, S
    Pollak, P
    Brice, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) : 422 - 423